Phased implementation of pathogen‐reduced platelets in a health system facilitates increased manufacturing at the blood center-Reference-Cited by-同舟云学术

Phased implementation of pathogen‐reduced platelets in a health system facilitates increased manufacturing at the blood center

Published:2019-08-13 Issue:10 Volume:59 Page:3120-3127
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Allen Elizabeth S.¹^ORCID,Vincent Colleen²,Reeve David A.³,Kopko Patricia M.¹

Affiliation:

1. Department of PathologyUniversity of California San Diego La Jolla California

2. The American Red Cross Pomona California

3. The American Red Cross Rockville Maryland

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15480

Reference22 articles.

1. Skin disinfection with a single-step 2% chlorhexidine swab is more effective than a two-step povidone-iodine method in preventing bacterial contamination of apheresis platelets

2. Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety

3. Use of hemovigilance data to evaluate the effectiveness of diversion and bacterial detection

4. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006)

5. Fatalities reported to FDA following blood collection and transfusion annual summary for FY2017. [Accessed August 8 2019] Available from:https://www.fda.gov/media/124796/download.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogen Reduction for Platelets—A Review of Recent Implementation Strategies;Pathogens;2022-01-24

2. Monte Carlo Simulation of Pathogen Reduced Platelet Production;Proceedings of the 12th International Conference on Simulation and Modeling Methodologies, Technologies and Applications;2022

3. Estimating the impact on the inventory of implementing pathogen‐reduced platelets in Canada;Transfusion;2021-10-06

4. Pathogen‐reduced platelets in pediatric and neonatal patients: Demographics, transfusion rates, and transfusion reactions;Transfusion;2021-08-27

5. Adoption trends of point of issue Verax PGD rapid test for bacterial screening of platelets between 2013 and 2018 among hospitals supplied by the American Red Cross and impact on platelet availability;Transfusion;2020-05-19